Cargando…
Evaluating Disparities in Proton Radiation Therapy Use in AHOD1331, a Contemporary Children's Oncology Group Trial for Advanced-Stage Hodgkin Lymphoma
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Particle Therapy Co-operative Group
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8768892/ https://www.ncbi.nlm.nih.gov/pubmed/35127976 http://dx.doi.org/10.14338/IJPT-21-00012.1 |
_version_ | 1784635018057875456 |
---|---|
author | Mailhot Vega, Raymond B. Castellino, Sharon M. Pei, Qinglin Parsons, Susan Roberts, Kenneth B. Hodgson, David Charpentier, Anne-Marie Fitzgerald, Thomas J. Kessel, Sandy K. Keller, Frank G. Kelly, Kara Hoppe, Bradford S. |
author_facet | Mailhot Vega, Raymond B. Castellino, Sharon M. Pei, Qinglin Parsons, Susan Roberts, Kenneth B. Hodgson, David Charpentier, Anne-Marie Fitzgerald, Thomas J. Kessel, Sandy K. Keller, Frank G. Kelly, Kara Hoppe, Bradford S. |
author_sort | Mailhot Vega, Raymond B. |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8768892 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | The Particle Therapy Co-operative Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-87688922022-02-03 Evaluating Disparities in Proton Radiation Therapy Use in AHOD1331, a Contemporary Children's Oncology Group Trial for Advanced-Stage Hodgkin Lymphoma Mailhot Vega, Raymond B. Castellino, Sharon M. Pei, Qinglin Parsons, Susan Roberts, Kenneth B. Hodgson, David Charpentier, Anne-Marie Fitzgerald, Thomas J. Kessel, Sandy K. Keller, Frank G. Kelly, Kara Hoppe, Bradford S. Int J Part Ther Editorial The Particle Therapy Co-operative Group 2021-10-28 /pmc/articles/PMC8768892/ /pubmed/35127976 http://dx.doi.org/10.14338/IJPT-21-00012.1 Text en ©Copyright 2021 The Author(s) https://creativecommons.org/licenses/by/3.0/This is an Open Access article distributed in accordance with Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0/ (https://creativecommons.org/licenses/by/3.0/) ). |
spellingShingle | Editorial Mailhot Vega, Raymond B. Castellino, Sharon M. Pei, Qinglin Parsons, Susan Roberts, Kenneth B. Hodgson, David Charpentier, Anne-Marie Fitzgerald, Thomas J. Kessel, Sandy K. Keller, Frank G. Kelly, Kara Hoppe, Bradford S. Evaluating Disparities in Proton Radiation Therapy Use in AHOD1331, a Contemporary Children's Oncology Group Trial for Advanced-Stage Hodgkin Lymphoma |
title | Evaluating Disparities in Proton Radiation Therapy Use in AHOD1331, a Contemporary Children's Oncology Group Trial for Advanced-Stage Hodgkin Lymphoma |
title_full | Evaluating Disparities in Proton Radiation Therapy Use in AHOD1331, a Contemporary Children's Oncology Group Trial for Advanced-Stage Hodgkin Lymphoma |
title_fullStr | Evaluating Disparities in Proton Radiation Therapy Use in AHOD1331, a Contemporary Children's Oncology Group Trial for Advanced-Stage Hodgkin Lymphoma |
title_full_unstemmed | Evaluating Disparities in Proton Radiation Therapy Use in AHOD1331, a Contemporary Children's Oncology Group Trial for Advanced-Stage Hodgkin Lymphoma |
title_short | Evaluating Disparities in Proton Radiation Therapy Use in AHOD1331, a Contemporary Children's Oncology Group Trial for Advanced-Stage Hodgkin Lymphoma |
title_sort | evaluating disparities in proton radiation therapy use in ahod1331, a contemporary children's oncology group trial for advanced-stage hodgkin lymphoma |
topic | Editorial |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8768892/ https://www.ncbi.nlm.nih.gov/pubmed/35127976 http://dx.doi.org/10.14338/IJPT-21-00012.1 |
work_keys_str_mv | AT mailhotvegaraymondb evaluatingdisparitiesinprotonradiationtherapyuseinahod1331acontemporarychildrensoncologygrouptrialforadvancedstagehodgkinlymphoma AT castellinosharonm evaluatingdisparitiesinprotonradiationtherapyuseinahod1331acontemporarychildrensoncologygrouptrialforadvancedstagehodgkinlymphoma AT peiqinglin evaluatingdisparitiesinprotonradiationtherapyuseinahod1331acontemporarychildrensoncologygrouptrialforadvancedstagehodgkinlymphoma AT parsonssusan evaluatingdisparitiesinprotonradiationtherapyuseinahod1331acontemporarychildrensoncologygrouptrialforadvancedstagehodgkinlymphoma AT robertskennethb evaluatingdisparitiesinprotonradiationtherapyuseinahod1331acontemporarychildrensoncologygrouptrialforadvancedstagehodgkinlymphoma AT hodgsondavid evaluatingdisparitiesinprotonradiationtherapyuseinahod1331acontemporarychildrensoncologygrouptrialforadvancedstagehodgkinlymphoma AT charpentierannemarie evaluatingdisparitiesinprotonradiationtherapyuseinahod1331acontemporarychildrensoncologygrouptrialforadvancedstagehodgkinlymphoma AT fitzgeraldthomasj evaluatingdisparitiesinprotonradiationtherapyuseinahod1331acontemporarychildrensoncologygrouptrialforadvancedstagehodgkinlymphoma AT kesselsandyk evaluatingdisparitiesinprotonradiationtherapyuseinahod1331acontemporarychildrensoncologygrouptrialforadvancedstagehodgkinlymphoma AT kellerfrankg evaluatingdisparitiesinprotonradiationtherapyuseinahod1331acontemporarychildrensoncologygrouptrialforadvancedstagehodgkinlymphoma AT kellykara evaluatingdisparitiesinprotonradiationtherapyuseinahod1331acontemporarychildrensoncologygrouptrialforadvancedstagehodgkinlymphoma AT hoppebradfords evaluatingdisparitiesinprotonradiationtherapyuseinahod1331acontemporarychildrensoncologygrouptrialforadvancedstagehodgkinlymphoma |